作者: Phillip Kim , Sharat Singh
DOI:
关键词: PI3K/AKT/mTOR pathway 、 Receptor tyrosine kinase 、 Signal pathway 、 Antibody 、 Enzyme 、 Glucose oxidase 、 Moiety 、 Pharmacology 、 Biochemistry 、 Biology 、 Protein subunit
摘要: The present invention provides methods for detecting, measuring and quantitating the activation states of components PI3K signaling pathway in cells such as tumor selecting an anticancer therapy therewith. involve a collaborative enzyme enhanced reactive-immunoassay (CEER) which first state-independent antibodies specific one member dimerised receptor tyrosine kinase (RTK) pair or p110 subunit are labeled with facilitating moiety (e.g. glucose oxidase) second dependent other RTK p85 signal amplification HRP).